Generic Name and Formulations:
Guanfacine (as HCl) 1mg, 2mg; tabs.
Promius Pharma, LLC
Indications for TENEX:
Initially 1mg/day at bedtime. May increase to 2mg/day at bedtime; usual max 3mg/day.
Severe coronary insufficiency. Recent MI. Cerebrovascular disease. Chronic renal or hepatic failure. Avoid abrupt cessation. Elderly. Labor & delivery: not recommended for treating hypertension due to pregnancy toxemia. Pregnancy (Cat.B). Nursing mothers.
Additive sedation with alcohol, other CNS depressants. Caution with microsomal enzyme inducing drugs (eg, barbiturates, phenytoin) in renal impairment.
Central alpha-2 agonist.
Dry mouth, somnolence, dizziness, headache, impotence, asthenia, constipation, fatigue.
Tabs 1mg—100, 500; 2mg—100
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics